HDAC2 and chronic obstructive pulmonary disease: HDAC2 activity is reduced in alveolar macrophages and lung tissue in COPD patients [77], and this reduced activity is linked to increased histone acetylation at the IL-8 promoter (FISCHER; VOYNOW; GHIO, 2015).